WIMAGINE (CEA‑Clinatec) epidural wireless ECoG implant
WIMAGINE (CEA‑Clinatec) epidural wireless ECoG implant
One-line verdict: A fully implanted, wireless epidural ECoG system that trades spatial precision and single-unit access for a safer surgical interface class and clinically robust long‑term recordings for human motor BCIs.
Quick tags: Recording · Closed-loop capable (system-dependent) · Species: Human · First implanted: ~2016
Overview
What it is: WIMAGINE is a fully implanted, wireless epidural ECoG brain–computer interface developed by CEA‑Clinatec for human motor restoration research. It records population-level cortical signals over motor cortex without penetrating brain tissue and transmits data wirelessly to external decoding systems.
Why it matters: WIMAGINE is a concrete demonstration that stable, long-term motor decoding is possible in humans using a non‑penetrating, fully implanted neural interface class — enabling high-profile demonstrations (e.g., exoskeleton control) while reducing biological risk relative to penetrating arrays.
Most comparable devices: subdural/epidural ECoG systems (signal class), other fully implanted wireless cortical surface interfaces.
Spec Card Grid
Identity
- Device name: WIMAGINE
- Canonical ID: BTSD-IMBCI-0004
- Inventor / key authors: Alim‑Louis Benabid et al.
- Org / manufacturer: CEA‑Clinatec (France)
- First demonstrated (year): ~2016 (reported)
- First implanted (year): ~2016 (reported)
- Species: human
- Regulatory / trial status: human research trial
- Primary use: recording
- Primary target: motor cortex (epidural over M1)
Geometry & Architecture
- Interface type: epidural ECoG
- Penetrating?: no
- Form factor: flexible electrode array
- Array layout: multi-contact ECoG grid
- Footprint (mm): cm-scale cortical coverage (reported)
- Insertion depth (mm): epidural (no cortical penetration)
- Shank / lead dimensions: N/A
- Site spacing (µm): mm-scale
- Tip geometry: flat contacts
- Insertion method: craniotomy with epidural placement
- Anchoring method: skull fixation
- Packaging location: fully implanted cranial module with wireless telemetry
Electrode & Channel Physics
- Channel count: ~64 (reported; configurations vary)
- Active sites used (vs total): majority active (reported)
- Electrode material: platinum-based contacts (reported)
- Site area (µm²): large surface contacts (ECoG-scale)
- Impedance @ 1 kHz: low (typical for ECoG; exact values vary)
- Noise floor / SNR: moderate; population-level signals
- Recording modality: ECoG (LFP-dominant)
- Stimulation capability: no (recording-focused)
- Charge injection limit / safe stim range: N/A
Tissue Interface & Bioresponse
- Target tissue: dura-adjacent cortical surface
- BBB disruption: low
- Vascular disruption risk: low
- Micromotion sensitivity: low
- Gliosis / encapsulation: generally lower than penetrating arrays; long-term encapsulation can still affect coupling
- Neuron loss (if reported): none reported (in summary sources)
- Foreign-body response mitigation: non-penetrating geometry
- Typical failure mode: coupling changes (encapsulation), hardware aging, telemetry/power issues
System Architecture
- Onboard electronics: amplification + digitization
- Data path: fully implanted wireless telemetry
- Telemetry bandwidth: sufficient for ECoG decoding (exact figures vary)
- Sampling rate: ECoG-appropriate (often hundreds of Hz to kHz in practice; exact varies)
- Power: implanted power module (inductive recharge reported)
- Thermal management: within safe cranial limits (reported)
- Hermeticity: medical-grade sealed implant
- MRI compatibility: unknown/conditional (device- and protocol-dependent)
- Surgical complexity: moderate craniotomy, low cortical risk (relative to penetrating arrays)
Performance Envelope
- Typical yield (acute): high
- Typical yield (chronic): stable multi-month recordings (reported)
- Stability over time: good
- Longevity (median / max): multi-year implants reported in this program
- Revision / explant: feasible
- Adverse events (high-level): none major reported in summary sources
- Notable demos / tasks: robotic exoskeleton control; motor intention decoding in tetraplegia
Clinical / Preclinical Evidence
- N implanted subjects: small human cohort
- Follow-up duration: months to years
- Indications: motor paralysis / tetraplegia
- Trial registry links: NCT02550522
- Primary outcomes: feasibility of wireless epidural motor BCI
- Key limitations of evidence: limited spatial resolution; small sample sizes; device specs not uniformly reported
Engineering Verdict
Strengths:
- strong safety profile relative to penetrating arrays
- fully implanted, wireless human system
- clinically realistic surgical burden
Limitations / failure modes:
- limited spatial and single-unit resolution
- decoding ceiling for surface/population signals
Scaling constraints:
- information density per unit area
- telemetry/power budget
- long-term coupling changes (encapsulation)
What newer designs try to fix:
- higher channel counts
- improved spatial specificity without penetrating tissue
References
- ClinicalTrials.gov: NCT02550522 (record access varies by site; link by ID): https://clinicaltrials.gov/study/NCT02550522
- (Add) Benabid AL et al., Lancet Neurology (2019) — to link precisely once we pick the exact article/DOI.
- CEA‑Clinatec: https://clinatec.fr/